Cargando…

Neuropathy induced by exogenously administered advanced glycation end‐products in rats

Aims/Introduction: Advanced glycation end‐products (AGE) have been implicated in the development of diabetic neuropathy. It still remains unknown, however, how AGE cause functional and structural changes of the peripheral nerve in diabetes. To explore the role of AGE in diabetic neuropathy, we exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishizawa, Yusuke, Wada, Ryu‐ichi, Baba, Masayuki, Takeuchi, Masayoshi, Hanyu‐Itabashi, Chieko, Yagihashi, Soroku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020676/ https://www.ncbi.nlm.nih.gov/pubmed/24843407 http://dx.doi.org/10.1111/j.2040-1124.2009.00002.x

Ejemplares similares

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver
por: Takata, Takanobu, et al.
Publicado: (2019)

The Impact of Low-Dose Insulin on Peripheral Nerve Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats
por: Sugimoto, Kazuhiro, et al.
Publicado: (2013)

Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population
por: Kudoh, Kazuhiro, et al.
Publicado: (2020)

Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2017)

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
por: Oshitari, Toshiyuki
Publicado: (2023)

Increased Oxidative Stress Underlies Abnormal Pain Threshold in a Normoglycemic Japanese Population
por: Osonoi, Sho, et al.
Publicado: (2020)

Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
por: Takeuchi, Masayoshi, et al.
Publicado: (2015)

Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy
por: Haga, Rie, et al.
Publicado: (2015)

Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments
por: Yorek, Mark, et al.
Publicado: (2018)

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men
por: Tahara, Nobuhiro, et al.
Publicado: (2010)

mRNA expression of delta-HER2 and its clinicopathological correlation in HER2-overexpressing breast cancer
por: Wada, Ryuichi, et al.
Publicado: (2016)

Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model
por: Inoue, Shinya, et al.
Publicado: (2020)

Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
por: Takata, Takanobu, et al.
Publicado: (2019)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
por: Takata, Takanobu, et al.
Publicado: (2020)

Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double‐blind placebo‐controlled trial
por: Satoh, Jo, et al.
Publicado: (2011)

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)

Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts
por: Takata, Takanobu, et al.
Publicado: (2022)

Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies
por: Juranek, Judyta K, et al.
Publicado: (2013)

Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: association with E-cadherin1 (CDH1) promoter methylation
por: Saito, Takeshi, et al.
Publicado: (2017)

Clinical staging of type 2 diabetes: The time has come
por: Yagihashi, Soroku
Publicado: (2012)

Imaging of insulin factory: Is it just imagination or approaching reality?
por: Yagihashi, Soroku
Publicado: (2012)

Diabetes and pancreas size, does it matter?
por: Yagihashi, Soroku
Publicado: (2016)

What can we learn from the islet of Joslin Medalists?
por: Yagihashi, Soroku
Publicado: (2020)

Gut as a source of new β‐cells and Segi's cap
por: Yagihashi, Soroku
Publicado: (2023)

Contribution of animal models to diabetes research: Its history, significance, and translation to humans
por: Yagihashi, Soroku
Publicado: (2023)

Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion
por: Takata, Takanobu, et al.
Publicado: (2017)

Use of Grape Pomace Phenolics to Counteract Endogenous and Exogenous Formation of Advanced Glycation End-Products
por: Sri Harsha, Pedapati S. C., et al.
Publicado: (2019)

RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells
por: Takino, Jun-ichi, et al.
Publicado: (2021)

Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2020)

Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway
por: Mizukami, Hiroki, et al.
Publicado: (2020)

Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation
por: Umetsu, Satoko, et al.
Publicado: (2020)

Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than N(ε)-(Carboxymethyl) Lysine
por: Yokota, Mami, et al.
Publicado: (2017)

The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2022)

Atorvastatin Reduces Proteinuria in Non-Diabetic Chronic Kidney Disease Patients Partly via Lowering Serum Levels of Advanced Glycation End Products (AGEs)
por: Nakamura, Tsukasa, et al.
Publicado: (2010)

Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes
por: Al-Saoudi, Elaf, et al.
Publicado: (2022)

Exploring a New Therapy for Diabetic Polyneuropathy – The Application of Stem Cell Transplantation
por: Mizukami, Hiroki, et al.
Publicado: (2014)

Expression of Type IV Collagen and Its Degrading Enzymes in Squamous Cell Carcinoma of Lung
por: Nakagawa, Hideyuki, et al.
Publicado: (1994)

Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation
por: Mastrocola, Raffaella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_upuroqeaatq3tg0lrv6t2knq0j